Lugaresi A, Pharmacology and clinical efficacy of dalfampridine for treating multiple sclerosis., «EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY», 2015, 11, pp. 295 - 306 [Scientific article]
Jokubaitis Vg; Spelman T; Kalincik T; Izquierdo G; Grand'Maison F; Duquette P; Girard M; Lugaresi A; Grammond P; Hupperts R; Cabrera-Gomez J; Oreja-Guevara C; Boz C; Giuliani G; Fernández-Bolaños R; Iuliano G; Lechner-Scott J; Verheul F; van Pesch V; Petkovska-Boskova T; Fiol M; Moore F; Cristiano E; Alroughani R; Bergamaschi R; Barnett M; Slee M; Vella N; Herbert J; Shaw C; Saladino Ml; Amato Mp; Liew D; Paolicelli D; Butzkueven H; Trojano M, Predictors of disability worsening in clinically isolated syndrome., «ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY», 2015, 2, pp. 479 - 491 [Scientific article]Open Access
Amato Maria; Hakiki Bahia; Pastò Luisa; Giannini Marta; Razzolini Lorenzo; Tortorella Carla; D'Onghia Mariangela; Trojano Maria; Cocco Eleonora; Melis Marta; Marrosu Maria; Tommaso Valeria Di; Farina Deborah; Lugaresi Alessandra; Annovazzi Pietro; Ghezzi Angelo; Gasperini Claudio; Iudice Alfonso; Fantozzi Roberta; Bellantonio Paolo; Messina Silvia; Patti Francesco; Masera Silvia; Cavalla Paola; Protti Alessandra; Rossi Maria; Totaro Rocco; Giglio Laura De; Pozzilli Carlo; Portaccio Emilio, Pregnancy does not prevent disease re-activation after natalizumab suspension in patients with multiple sclerosis, «NEUROLOGY», 2015, 84, pp. 20 - 20 [Abstract]
A. Lugaresi; GT Maniscalco; A. Giordano; V. Martinelli; F. Patti; E. Pietrolongo; M. Zaffaroni; S. Borghesan; A. Solari, Role preferences of relapsing MS patient in Italy, «INTERNATIONAL MS JOURNAL», 2015, 21, pp. 515 - 516 [Abstract]
Kalincik T; Horakova D; Spelman T; Jokubaitis V; Trojano M; Lugaresi A; Izquierdo G; Rozsa C; Grammond P; Alroughani R; Duquette P; Girard M; Pucci E; Lechner-Scott J; Slee M; Fernandez-Bolanos R; Grand'Maison F; Hupperts R; Verheul F; Hodgkinson S; Oreja-Guevara C; Spitaleri D; Barnett M; Terzi M; Bergamaschi R; McCombe P; Sanchez-Menoyo J; Simo M; Csepany T; Rum G; Boz C; Havrdova E; Butzkueven H; on behalf of the MSBase Study Group, Switch to natalizumab vs fingolimod in active relapsing-remitting multiple sclerosis., «ANNALS OF NEUROLOGY», 2015, 77, pp. 425 - 435 [Scientific article]
E. Portaccio; B. Goretti; C. Niccolai; B. Hakiki; M. iannini; L. Pastò; C. Pecori; L. Razzolini; M. Falautano; E. Minacapelli; V. Martinelli; C. Incerti; U. Nocentini; M. Murgia; G. Fenu; E. Cocco; MG Marrosu; E. Garofalo; FI Ambra; M. Maddestra; M. Consalvo; RG Viterbo; M. Trojano; NA Losignore; GB Zimatore; E. Pietrolongo; A. Lugaresi; L. Pippolo; M. Roscio; A. Ghezzi; D. Castellano; S. Stecchi; MP Amato., A comparison of the Brief International Cognitive Assessment for Multiple Sclerosis and a brief repeatable battery in multiple sclerosis patients., «MULTIPLE SCLEROSIS», 2014, 20, pp. 124 - 125 [Abstract]
E. Portaccio; B. Goretti; C. Niccolai; B. Hakiki; M. Giannini; L. Pastò; C. Pecori; F. Razzolini; M. Falautano; E. Minacapelli; V. Martinelli; C. Incerti; U. Nocentini; M.
Murgia; G. Fenu; E. Cocco; M. Marrosu; E. Garofalo; F. Ambra; M. Maddestra; M.
Consalvo; R. Viterbo; M. Trojano; N. Losignore; G. Zimatore; E. Pietrolongo; A. Lugaresi; L. Pippolo; M. Roscio; A. Ghezzi; D. Castellano; S. Stecchi; M. Amato, A comparison of the brief International cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients., «NEUROLOGICAL SCIENCES», 2014, 35, pp. 65 - 65 [Abstract]
V. Di Tommaso; L. Mancinelli; M. Matteo; D. Travaglini; D. Farina; M. di Ioia; G. De Luca; E. Pietrolongo; A. Lugaresi, Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis., «NEUROLOGICAL SCIENCES», 2014, 35, pp. 355 - 356 [Abstract]
T. Kalincik; D. Horakova; T. Spelman; V. Jokubaitis; M. Trojano; A. Lugaresi; G. Izquierdo; C. Rozsa; P.Grammond; R. Alroughani; P. Duquette; M. Girard; E. Pucci; J. Lechner-Scott; M. Slee; R. Fernandez-Bolanos; F. Grand’Maison; R. Hupperts; F. Verheul; S. Hodgkinson; C. Oreja-Guevara; D. Spitalieri; M. Barnett; M. Terzi; R. Bergamaschi; P. McCombe; J. Sanchez- Menoyo; M. Simo; T. Csepany; G. Rum; C. Boz; E. Havrdova; H. Butzkueven; Ms Base Study Group., Comparative efficacy of switch to natalizumab of fingolimod in active relapsing.remitting multiple sclerosis, «MULTIPLE SCLEROSIS», 2014, 20, pp. 195 - 196 [Abstract]
A. He; T. Spelman; V Jokubaitis; A. Lugaresi; G. Izquiero; M. Trojano; P. Grammond; J. Lechner-Scott; P. Duquette; M. Girard; E. Pucci; M. Slee; F. Grand’Maison; C . Oreja-Guevara; C. Boz; R. Fernandez-Bolanos; S. Hodgkinson; J. Sanchez-Menoyo; G. Iuliano; M. Barnett; F. Moore; H. Butzkueven; T. Kalincik; Ms Base Study Group., Comparison of fingolimod versus interferon-beta/glatiramer acetate as second-line therapy in active multiple sclerosis, «MULTIPLE SCLEROSIS», 2014, 20, pp. 193 - 193 [Abstract]
M. di Ioia; D. Pieragostino; C. Rossi; M. Zucchelli; M. D’Alessandro; A. Lugaresi; D. Travaglini; D. Farina; P. Sacchetta; P. Del Boccio, Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients, «NEUROLOGICAL SCIENCES», 2014, 35, pp. 335 - 335 [Abstract]
A. Bertolotto; F. Marnetto; M. Caldano; A. Lugaresi; M. Spadaro, Effect of Natalizumb treatment on circulating CD4+CD62L+T-cells in multiple sclerosis patients., «NEUROLOGICAL SCIENCES», 2014, 35, pp. 277 - 277 [Abstract]
Bertolotto A.; Capobianco M.; Amato M.P.; Capello E.; Capra R.; Centonze D.; Di Ioia M.; Gallo A.; Grimaldi L.; Imberti L.; Lugaresi A.; Mancinelli C.; Marrosu M.G.; Moiola L.; Montanari E.; Romano S.; Musu L.; Paolicelli D.; Patti F.; Pozzilli C.; Rossi S.; Salvetti M.; Tedeschi G.; Tola M.R.; Trojano M.; Zaffaroni M.; Malucchi S., Erratum: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: Report from the Italian Multiple Sclerosis Study group (Neurological Sciences (2014)), «NEUROLOGICAL SCIENCES», 2014, 35, pp. 1645 - 1646 [Comment or similar]
T. Kalincik; V. Jokubaitis; T. Spelman; D. Horakova; E. Havrdova; M. Trojano; G. Izquierdo; M. Girard; P. Duquette; A. Lugaresi; F. Grand’Maison; P. Grammond; R. Hupperts; C. Oreja-Guevara; E. Pucci; C. Boz; R. Bergamaschi; J. Lechner-Scott; L. Alroughani; V.Van Pesch; G. Iuliano; M. Rio; R. Fernande-Bolanos; C. Ramo; M. Terzi; T. Petersen; M. Slee; D. Spitalieri; MP Amato; F Verheul; E. Cristiano; J. Sanchez-Menoyo; M. Fiol; O. Gray; JA. Cabrera-Gomez; S. Hodgkinson; M. Barnett; M. Saladino; S. Vucic; C. Shaw; F. Moore; E Van Muster; C. Rozsa; P. McCombe; H. Butzkueven, Evaluation of common criteria of progression of disability in a large observational cohort., «MULTIPLE SCLEROSIS», 2014, 20, pp. 62 - 63 [Abstract]
Borreani C; Giordano A; Falautano M; Lugaresi A; Martinelli V; Granella F; Tortorella C; Plasmati I; Radaelli M; Farina D; Dalla Bella E; Bianchi E; Acquarone N; Miccinesi G; Solari A; SIMS-Trial group [ ..; Mattarozzi K; ], Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial., «HEALTH EXPECTATIONS», 2014, 17, pp. 36 - 48 [Scientific article]
